Mechanisms of Autophagy
Mechanisms of Autophagy
批准号:
10915983
负责人:
Richard James Youle
金额:
$188.26万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdoptedAffinityAutophagocytosisAutophagosomeBacteriaBiologicalBrainC-terminalCell SurvivalCellsClawCollaborationsComplexCryoelectron MicroscopyDevelopmentEctopic ExpressionEncapsulatedEukaryotic CellGenerationsHomeostasisHumanInduced pluripotent stem cell derived neuronsInvestigationKnockout MiceLettersLigandsLinkLipofuscinLysosomesMaintenanceMapsMediatingMembraneMitochondriaMolecularMolecular WeightMusMutationN-terminalNatural ImmunityNerve DegenerationNeurodegenerative DisordersNutrientNutrient availabilityOrganellesPINK1 geneParkinParkinson DiseasePathway interactionsPharmaceutical PreparationsPhosphotransferasesProteinsQuality ControlShapesStarvationStressTBK1 geneTherapeuticToxic effectUbiquitinationcytotoxicdimerextracellularflexibilityin vivomisfolded proteinmitochondrial autophagyneuronal survivalprematureprotein aggregationproteotoxicityreceptorrecruitscaffoldscreeningsingle molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Autophagy is known to be required for eukaryotic cells to withstand nutrient starvation by mediating the degradation of cellular components to supply substrates for ATP generation thereby helping cells survive until extracellular nutrient availability returns. Autophagy also mediates forms of quality control within cells by engulfing and degrading protein aggregates and damaged mitochondria that mitigates neurodegeneration in mice. Autophagy substrates become encapsulated by a double membrane structure that then fuses with lysosomes to mediate degradation of the cargo. How autophagosomes form and how their substrates are recognized for engulfment remain poorly understood. Numerous types of selective autophagy have been examined, and some progress has been made in determining the basis of cargo selectivity. The autophagy receptor proteins OPTN, NDP52, TAX1BP1 and p62 are known to be important in autophagy of bacteria for innate immunity, whereas OPTN, NDP52, and to a lesser extent, TAX1BP1 are essential for PINK1/Parkin-mediated mitophagy linked to Parkinsons disease. How protein aggregates are recognized by autophagosomes, however, is unclear.
1) Protein aggregates disrupt cellular homeostasis, causing toxicity linked to neurodegeneration and ways to eliminate them are under intense investigation, including autophagic engulfment and degradation of them. We compared the requirements for autophagy receptor proteins: OPTN, NBR1, p62, NDP52, and TAX1BP1 in clearance of proteotoxic aggregates. Endogenous TAX1BP1 is recruited to and required for the clearance of stress-induced aggregates, whereas ectopic expression of TAX1BP1 increases clearance through autophagy, promoting viability of human induced pluripotent stem cell-derived neurons. In contrast, TAX1BP1 depletion sensitizes cells to several forms of aggregate-induced proteotoxicity. Furthermore, TAX1BP1 is more specifically expressed in the brain compared to other autophagy receptor proteins. In vivo, loss of TAX1BP1 results in accumulation of high molecular weight ubiquitin conjugates and premature lipofuscin accumulation in brains of young TAX1BP1 knockout mice. TAX1BP1 mediates clearance of a broad range of cytotoxic proteins indicating therapeutic potential in neurodegenerative diseases.
2) Autophagy of mitochondria and protein aggregates is initiated by the ULK complex, which consists of the kinase ULK1, FIP200, ATG13, and ATG101. In collaboration with a group at UC Berkeley, we mapped the structural basis and biological consequences of their mutual interactions. The N-terminal domain of FIP200 interact with the C-terminal domain of ATG13. Mutations in these regions abolish their interaction. FIP200 forms a dimer, while only a single molecule each of the other subunits is present in the ULK complex. The FIP200 N-terminal domain is flexible in the absence of ATG13, but in its presence adopts the shape of the letter C 20 nm across. The ULK1 EAT domain interacts loosely with the N-terminal domain dimer, while the ATG13:ATG101 HORMA dimer does not contact the N-terminal domain. Cryo-EM of the N-terminal domain dimer revealed a structural similarity to the scaffold domain of TBK1, suggesting an evolutionary similarity between the autophagy-initiating TBK1 kinase and the ULK1 kinase complex. Interestingly, TBK1 functions in PINK1/Parkin mediated mitophagy and in STING activation of innate immunity and is under our investigation in both those pathways. The claw domain on Fib200 appears to be a potential drug pocket that we are screening for high affinity ligands. Identification of such may allow AutoTACs development to eliminate protein aggregates involved in neurodegeneration.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.ceb.2011.05.007
发表时间:
2011-08
期刊:
CURRENT OPINION IN CELL BIOLOGY
影响因子:
7.5
作者:
[Karbowski, Mariusz, Youle, Richard J.]
通讯作者:
Youle, Richard J.
Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance.
线粒体维护中的线粒体和质量控制机制。
DOI:
10.1016/j.cub.2018.01.004
发表时间:
2018-02-19
期刊:
Current biology : CB
影响因子:
--
作者:
[Pickles S, Vigié P, Youle RJ]
通讯作者:
Youle RJ
DOI:
10.1186/s12915-017-0470-7
发表时间:
2018-01-10
期刊:
BMC biology
影响因子:
5.4
作者:
[Sekine S, Youle RJ]
通讯作者:
Youle RJ
DOI:
10.1016/j.devcel.2011.12.014
发表时间:
2012-02-14
期刊:
DEVELOPMENTAL CELL
影响因子:
11.8
作者:
[Lazarou, Michael, Jin, Seok Min, Kane, Lesley A., Youle, Richard J.]
通讯作者:
Youle, Richard J.
Sequestration and autophagy of mitochondria do not cut proteins across the board.
线粒体的隔离和自噬不会全面切割蛋白质。
DOI:
10.1073/pnas.1303921110
发表时间:
2013
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Huang,Chiu-Hui, Lazarou,Michael, Youle,RichardJ]
通讯作者:
Youle,RichardJ
共 10 条
Engineering Cell Type Specific Toxins
-
批准号:7323060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Mechanisms of Autophagy
-
批准号:8557093
-
项目类别:
-
资助金额:$67.33万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:8342293
-
项目类别:
-
资助金额:$181.11万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:6990654
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:8746848
-
项目类别:
-
资助金额:$204.9万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:9563160
-
项目类别:
-
资助金额:$112.91万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:7735271
-
项目类别:
-
资助金额:$159.85万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Central Nervous System Drug Delivery Techniques
-
批准号:10018688
-
项目类别:
-
资助金额:$30.56万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Neuro-oncology of Familial Neoplasia Syndromes
-
批准号:10018690
-
项目类别:
-
资助金额:$79.14万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Role of mitochondria in neurodegenerative diseases
-
批准号:10688932
-
项目类别:
-
资助金额:$171.83万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:10688926
-
项目类别:
-
资助金额:$54.7万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Central Nervous System Drug Delivery Techniques
-
批准号:10253920
-
项目类别:
-
资助金额:$30.88万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Mechanisms of Autophagy
-
批准号:10265219
-
项目类别:
-
资助金额:$60.23万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Molecular Pathogenesis of Neoplasia
-
批准号:8940096
-
项目类别:
-
资助金额:$101.99万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:8557014
-
项目类别:
-
资助金额:$101.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Molecular Pathogenesis of Neoplasia
-
批准号:9157542
-
项目类别:
-
资助金额:$100.21万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:9563103
-
项目类别:
-
资助金额:$65.03万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Programmed Cell Death In The Nervous System
-
批准号:9358539
-
项目类别:
-
资助金额:$80.87万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
Neuro-oncology of Familial Neoplasia Syndromes
-
批准号:9563146
-
项目类别:
-
资助金额:$64.63万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
ENGINEERING CELL TYPE SPECIFIC TOXINS
-
批准号:6432897
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Richard James Youle
-
依托单位:
海外基金